Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effects

Read full text
Authors: Sriram Pendyala, Katie Partington, Nicholas J. Bradley, Abbye E. McEwen, Gwenneth Straub, Hyeon-Jin Kim, Shawn Fayer, Daniel L. Holmes, Katherine A. Sitko, Riddhiman K. Garge, Ziyu R. Wang, Melinda K. Wheelock
+11 more Allyssa Vandi, Rachel L. Powell, Clayton E. Friedman, Evan McDermot, Nishka Kishore, Frederick P. Roth, Alan F. Rubin, Kai‐Chun Yang, Lea M. Starita, William Stafford Noble, Douglas M. Fowler
Cited by: 3
References: 139

Abstract

Genetic variants produce complex phenotypic effects that confound current assays and predictive models. We developed variant in situ sequencing (VIS-seq), a pooled, image-based method measuring variant effects on molecular and cellular phenotypes in diverse cell types. Applying VIS-seq to ∼3,000 LMNA and PTEN variants yielded high-dimensional morphological profiles capturing changes in protein abundance, localization, activity, and cell architecture. VIS-seq identified a subset of linker-subdomain LMNA variants that increase nuclear circularity, in contrast to aggregating or low-abundance rod-subdomain variants that decrease circularity. VIS-seq also identified autism-associated PTEN variants that mislocalize and accurately distinguished autism-linked from tumor syndrome-linked and gnomAD control variants. Most variants impacted a multidimensional phenotypic continuum not recapitulated by any single functional readout. By linking variants to cell images at scale, VIS-seq illuminates how variant effects cascade from molecules to subcellular structures to cells, providing a framework for resolving the complexity of variant function.

Fields of Study & Subjects

CRISPR and Genetic Engineering Cancer Genomics and Diagnostics PI3K/AKT/mTOR signaling in cancer

Publication details

Journal / source
Cell
Publisher
Elsevier BV
Volume
189
Issue
13
Pages
4040–4058.e31
Publication date
12 May 2026
Language
EN